Literature DB >> 1554824

Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection.

M Kielhofner1, R L Atmar, R J Hamill, D M Musher.   

Abstract

Bacterial infections are a well-described complication of AIDS. However, relatively few reports have described infections due to Pseudomonas aeruginosa in adults who are infected with the human immunodeficiency virus (HIV). Seven cases of serious P. aeruginosa infection in HIV-infected patients occurred during 12 months in two hospitals in Houston, often in the absence of other host factors that are generally thought to predispose to this condition. One patient had no prior illness or antibody test results that were suggestive of HIV infection; for two other patients who were known to have antibody to HIV, an AIDS-defining diagnosis had never been made. Three patients had pneumonia (two with bacteremia and one with empyema), one had malignant otitis externa, and three had bacteremia that either resulted from or caused secondarily a soft-tissue focus of infection. Two patients died, and two others experienced one or more relapses after an initial course of treatment. Compromised host defense mechanisms, including loss of mucosal integrity, defects in humoral and cellular immunities, and qualitative or quantitative leukocyte abnormalities, may predispose HIV-infected patients to P. aeruginosa infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554824     DOI: 10.1093/clinids/14.2.403

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Complete genome sequence of Pseudomonas aeruginosa siphophage MP1412.

Authors:  Hee-Won Bae; In-Young Chung; Nuri Sim; You-Hee Cho
Journal:  J Virol       Date:  2012-09       Impact factor: 5.103

2.  Localised upper airway obstruction in a patient with acquired immunodeficiency syndrome.

Authors:  C L D'Arsigny; S Ford; D E O'Donnell
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

3.  Functional characterization of WaaL, a ligase associated with linking O-antigen polysaccharide to the core of Pseudomonas aeruginosa lipopolysaccharide.

Authors:  Priyanka D Abeyrathne; Craig Daniels; Karen K H Poon; Mauricia J Matewish; Joseph S Lam
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

4.  Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.

Authors:  Diansy Zincke; Deepak Balasubramanian; Lynn L Silver; Kalai Mathee
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

5.  Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

6.  Recovery of Pseudomonas aeruginosa in respiratory specimens from HIV positive patients being evaluated for Pneumocystis carinii pneumonia.

Authors:  R L Doyle; J J Doherty; L H Zimmerman
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

7.  Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.

Authors:  M Millesimo; G de Intinis; M G Chirillo; T Musso; D Savoia
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

8.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Superinfection exclusion reveals heteroimmunity between Pseudomonas aeruginosa temperate phages.

Authors:  In-Young Chung; Hee-Won Bae; Hye-Jung Jang; Bi-o Kim; You-Hee Cho
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

10.  Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model.

Authors:  Pooja Manchandani; Jian Zhou; Kimberly R Ledesma; Luan D Truong; Diana S-L Chow; Jason L Eriksen; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.